Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cogent Biosciences Inc.

    NASDAQ: COGT · Real-Time Price · USD
    11.72
    -0.04 (-0.34%)
    At close: Aug 20, 2025, 10:01 AM

    Cogent Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 4.4M 3.59M 5.88M 147K
    Gross Profit
    		 -4.4M -3.59M -5.88M -147K
    Operating Income
    		 -275.94M -208.13M -147.84M -75.55M
    Interest Income
    		 18.09M 13.08M 3.99M 467K
    Pretax Income
    		 -255.86M -192.41M -140.24M -72.27M
    Net Income
    		 -255.86M -192.41M -132.64M -71.81M
    Selling & General & Admin
    		 43.28M 34.38M 26.21M 19.64M
    Research & Development
    		 232.66M 170.17M 121.63M 55.91M
    Other Expenses
    		 n/a n/a 3.61M n/a
    Operating Expenses
    		 275.94M 208.13M 147.84M 75.55M
    Interest Expense
    		 n/a n/a 3.99M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 275.94M 208.13M 147.84M 75.55M
    Income Tax Expense
    		 n/a n/a n/a -467K
    Shares Outstanding (Basic)
    		 103.86M 79.66M 58.74M 38.73M
    Shares Outstanding (Diluted)
    		 103.86M 79.66M 58.74M 38.73M
    EPS (Basic)
    		 -2.46 -2.42 -2.26 -1.85
    EPS (Diluted)
    		 -2.46 -2.42 -2.26 -1.85
    EBITDA
    		 -275.94M -205.86M -134.36M -75.4M
    EBIT
    		 -275.94M -208.13M -147.84M -75.55M
    Depreciation & Amortization
    		 2.45M 2.27M 5.88M 147K

    Add to Watchlist